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Abstract
Background: We evaluated brief combination interventions to simultaneously reduce sexual and injection risks among
female sex workers who inject drugs (FSW-IDUs) in Tijuana and Ciudad Juarez, Mexico during 2008–2010, when harm
reduction coverage was expanding rapidly in Tijuana, but less so in Juarez.
Methods: FSW-IDUs $18 years reporting sharing injection equipment and unprotected sex with clients within the last
month participated in a randomized factorial trial comparing four brief, single-session conditions combining either an
interactive or didactic version of a sexual risk intervention to promote safer sex in the context of drug use, and an injection
risk intervention to reduce sharing of needles/injection paraphernalia. Women underwent quarterly interviews and testing
for HIV, syphilis, gonorrhea, Chlamydia and Trichomonas, blinding interviewers and assessors to assignment. Poisson
regression with robust variance estimation and repeated measures ordinal logistic regression examined effects on
combined HIV/STI incidence and receptive needle sharing frequency.
Findings: Of 584 initially HIV-negative FSW-IDUs, retention was $90%. After 12 months, HIV/STI incidence decreased .50%
in the interactive vs. didactic sex intervention (Tijuana:AdjRR:0.38,95% CI:0.16–0.89; Juarez: AdjRR:0.44,95% CI:0.19–0.99). In
Juarez, women receiving interactive vs. didactic injection risk interventions decreased receptive needle-sharing by 85% vs.
71%, respectively (p = 0.04); in Tijuana, receptive needle sharing declined by 95%, but was similar in active versus didactic
groups. Tijuana women reported significant increases in access to syringes and condoms, but Juarez women did not.
Interpretation: After 12 months in both cities, the interactive sexual risk intervention significantly reduced HIV/STI
incidence. Expanding free access to sterile syringes coupled with brief, didactic education on safer injection was necessary
and sufficient for achieving robust, sustained injection risk reductions in Tijuana. In the absence of expanding syringe access
in Juarez, the injection risk intervention achieved significant, albeit more modest reductions, suggesting that community-
level interventions incorporating harm reduction are more powerful than individual-level interventions.
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Introduction
Globally, female sex workers (FSWs) experience elevated risks of
acquiring HIV and other sexually transmitted infections (STIs). In
a recent meta-analysis of 50 countries, overall HIV prevalence was
11.8% and compared to other women of reproductive age, the
pooled odds ratio of HIV infection among FSWs was 13.5% [1].
These estimates under-represent HIV infection among FSWs who
inject drugs (FSW-IDUs) who experience heightened risk of HIV
and STIs through two transmission routes: unprotected sexual
intercourse and sharing injection equipment with intimate
partners, clients and peers [2].
FSW-IDUs are vulnerable to acquiring and transmitting HIV/
STIs because of biological, behavioural and structural factors [2].
Biologically, the probability of acquiring HIV per intravenous
drug injection is between 0.63% to 2.4% [3], and the probability
of acquiring HIV per unprotected male-to-female vaginal sex act is
0.124% [4]. However, the probability of a male acquiring HIV
from an HIV-infected FSW is estimated at 2.442% per transaction
[4].
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Addiction can elevate the probability of sharing injection
equipment or having unprotected sex. Engaging in sex work
under the influence of drugs, or injecting drugs with clients [5] can
compromise one’s ability to negotiate safe sex [6] or avoid sharing
injection equipment. Drug use and accompanying withdrawal
symptoms have also been associated with having unprotected sex
in exchange for more money [7] or being more likely to acquiesce
to clients’ demands to forgo condoms [8,9]. Structural factors
related to policing practices and working in outdoor spaces have
also been associated with elevated HIV risks among FSWs who use
injection and non-injection drugs [5,10].
Considerable overlap between FSW and IDU populations has
been documented in parts of Southeast and Central Asia [11,12],
Eastern Europe[13–15] Africa [16], Latin America [17] and
North America [18], including Mexico [19]. In an earlier study of
FSWs in Tijuana and Ciudad (Cd.) Juarez –two Mexican-U.S.
border cities adjacent to San Diego, CA and El Paso, TX
respectively– 18% of FSWs reported injecting drugs [8]. In Cd.
Juarez and Tijuana, HIV prevalence among FSWs increased from
2% in the 1990’s to 8% by 2006 [20], and 12% among FSW-
IDUs) [8]. In 2008, the states of Chihuahua and Baja California,
where these cities are located ranked 3rd and 4th in HIV
prevalence respectively among Mexico’s 32 states [21]. In Tijuana
alone, approximately one in 112 adults aged 15–49 was HIV-
infected [22]. HIV prevalence among IDUs in Tijuana has
remained stable at 4% among males but was 10% among females
in 2006–2007 [23]; in Cd. Juarez, HIV prevalence rose from 4%
in 2005 [24] to 7% in 2011 (personal communication, Dr. Carlos
Magis-Rodriguez, 2012).
Tijuana and Cd. Juarez are both located on major drug
trafficking corridors through which heroin, methamphetamine
and cocaine are transported [25]. In both cities, injection and non-
injection stimulant use were both independently associated with
HIV infection among FSWs [20], and prevalence of infectious
syphilis (i.e., titers $1:8), gonorrhea and Chlamydia was
significantly higher among FSW-IDUs at 22.7%, 15.2% and
21.2% compared to 13.1%, 5.2% and 11.9%, respectively among
other FSWs [8]. In Tijuana, half of female IDUs reported trading
sex, among whom HIV prevalence was 10% [23].
Efforts to reduce HIV risk among the most vulnerable FSWs are
needed since FSWs account for nearly one fifth of reported HIV
infections among women of reproductive age in Mexico, and
because the quasi-legal status of sex work in Mexico attracts large
numbers of clients from the U.S. and elsewhere. Globally, there is
a dearth of interventions that have focused on FSWs who use
drugs [2].
We previously conducted a two-arm randomized trial Mujer
Segura (Safe Woman) from 2004–2006 to evaluate whether a thirty-
minute, theoretically-based motivational interviewing (MI) inter-
vention would significantly increase negotiation of condom use
among FSWs in Tijuana and Cd. Juarez. The intervention was
associated with a 40% reduction in combined HIV/STI incidence,
significantly fewer unprotected sex acts compared to the control
condition [26] and was cost-effective [27]. However, FSW-IDUs
improved less than FSWs who did not inject drugs and the
frequency of needle sharing was unchanged, which was anticipat-
ed since this intervention did not attempt to intervene upon drug
use behaviors or sexual risk behaviors in the context of drug use
[28].
Recognizing that interventions which narrowly focus only on
safer sex or safer injection will be of limited effectiveness for FSW-
IDUs given their extreme vulnerability, we designed a four-arm
factorial randomized control trial called Mujer Mas Segura (Safer
Woman) to simultaneously test the efficacy of two behavioral
interventions aimed at increasing condom use in the context of
ongoing drug use and decreasing sharing of injection equipment
among FSW-IDUs. Women received both interventions in one of
two formats, an interactive version or a didactic version that served
as a control. We hypothesized that the joint effects of the
interactive format of both interventions would generate greater
risk reductions compared to the didactic formats. We also
examined whether intervention effects differed between the two
cities since availability of sterile syringes, injection paraphernalia
and condoms began expanding rapidly in Tijuana during the
study period, but was more limited in Cd. Juarez [29].
Methods
Ethics Statement
Women deemed potentially eligible underwent written in-
formed consent and were queried to ensure that they understood
what was required for study participation. The study protocol was
approved by Institutional Review Boards in the US (University of
California, San Diego, [UCSD]), and Mexico (Centro Nacional
para la Prevencion de VIH/SIDA [CENSIDA], Universidad
Autonoma de Ciudad Juarez and Hospital General de Tijuana.
Participants
Between October, 2008 and July, 2010, FSW-IDUs were
recruited into a randomized controlled trial in Tijuana and Cd.
Juarez, Mexico, as described previously [29] (see Checklist S1 and
Protocol S1).
Inclusion criteria. Participants were required to: (i) be
biologically female, (ii) be at least 18 years old, (iii) report
exchanging sex for money, drugs, shelter or goods in the last
month, (iv) report injecting drugs at least once in the last month, (v)
report having had unprotected vaginal or anal sex with male
clients at least once during the previous month and (vi) report
having shared needles, syringes or other injection paraphernalia
(i.e., cookers, cotton, rinse water) at least once within the last
month; (vii) test HIV-negative at baseline, and (viii) agree to
receive antibiotic treatment for Chlamydia, gonorrhea or syphilis.
Recruitment. As previously described, project staff ap-
proached women at venues frequented by FSWs and IDUs in
both cities (e.g., motels, hotels, brothels, shooting galleries, bars,
alleys, street corners). Women expressing interest in the study were
referred to the project office or a mobile unit for eligibility
screening. A five-minute survey served as a screener for study
eligibility, based on the above criteria. Staff also checked for
injection stigmata (i.e., track marks). Women deemed potentially
eligible underwent informed consent and HIV rapid tests.
Data Collection
Baseline interview. Surveys were administered using com-
puter-assisted personal interviewing (CAPI; NOVA software, MD,
USA), by bi-cultural female staff who were familiar with the local
population. The baseline survey collected data on socio-demo-
graphic and family background, sources of income, history,
practices and environmental influences regarding substance use
(type and frequency of injection and non-injection drug use,
alcohol use), receptive and distributive sharing of syringes,
injection and non-injection paraphernalia, frequency of injection
and syringe sharing, syringe cleaning, needing help injecting, drug
use and needle sharing in jail and history of drug treatment. We
also collected data on accessibility of sterile syringes, barriers to
purchasing and carrying syringes, shooting gallery attendance, and
frequency of arrest and incarceration for charges related to drug
possession and paraphernalia. FSWs were also asked to report
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whether they used alcohol or used injection and non-injection
drugs before or during sex with regular, casual and client partners
over the past month.
Sexual behaviors included number and frequency of unpro-
tected vaginal and anal sex with clients, spouse/steady partners
and casual male partners in the past month; number of partners
who inject drugs, number of female sex partners, and use of the
male and/or female condom.
We also collected data on contextual factors such as work
setting, having a pimp or manager, selected client characteristics
(e.g., demands for unprotected sex, client aggression or violence),
amounts received for protected vs. unprotected vaginal and anal
sex, and perceived changes in HIV/STI prevention services (i.e.,
availability of condoms, sterile syringes, HIV testing and medical
care). Follow-up interviews and HIV/STI testing were conducted
four, eight and twelve months’ post-randomization.
Randomization. Participants were assigned to one of four
groups based on a randomization schedule that was generated a
priori by the study statistician that was not disclosed to the
interviewers, ensuring that they were blind to group assignment.
Intervention and control conditions. 584 HIV-negative
women meeting our eligibility criteria (284 in Tijuana and 300 in
Ciudad Juarez) were randomized to one of four conditions in a
262 factorial design. Each of the four conditions was delivered by
trained female, bicultural counselors and included either an
interactive or didactic version of the injection risk intervention and
the sexual risk intervention, each 30 minutes in length. Therefore,
each of the four conditions lasted approximately 60 minutes to
complete, which served as an attention control. These modules
were described in detail previously [29] and are summarized
below.
Group A (i.e., Didactic Injection Risk Intervention and Didactic Sexual
Risk Intervention) represented the control condition and took 60
minutes to complete. This group received information on both
safer injection and safer sex that was delivered in a lecture-style
format which was based on information in printed materials
available at local health centers. Counselors were instructed not to
encourage discussion. In the Didactic Injection Risk portion of the
Intervention (30 minutes), the counselor stressed the importance of
using sterile injection equipment to protect against HIV and viral
hepatitis and the risks of transmission from sharing injection
equipment, provided referrals to the local needle exchange and
instructions on how to disinfect syringes with bleach when sterile
syringes were unavailable. No theory-driven or skills-building
elements focusing on safer injection were included. In the Didactic
Sexual Risk portion of the Intervention (30 minutes), the counselor
presented information based on a modified version of the CDC
guidelines for HIV counseling, testing, and referral [30] and
materials from CENSIDA that were used in the control condition
of Mujer Segura [26]. No theory-driven active skills-building
elements focused on safer sex were included.
For Group B (i.e. the Interactive Injection Risk Intervention and
Didactic Sexual Risk Intervention), participants received the
interactive injection risk reduction intervention and the didactic
sexual risk intervention which also required 60 minutes to
complete. The Interactive Injection Risk portion of the Interven-
tion required approximately 30 minutes to complete. Components
from the injection risk intervention were adapted from two
randomized behavioral intervention trials conducted in the U.S.
that were efficacious in reducing injection risks among IDUs [31]
and incorporated Motivational Interviewing (MI), Social Cognitive
Theory (SCT), and Theory of Reasoned Action (TRA). Both
interventions significantly reduced receptive and distributive
sharing of injection equipment [32,33] (http://www.cdc.gov/
hiv/topics/testing/non-healthcare/index.htm) [34]. Participants
viewed a 4-minute video called ‘‘Una Gota de Sangre’’ that was
created for the project and featured FSW-IDUs from Tijuana.
The video depicted an improvised scene that illustrated how
injection equipment can become contaminated with blood-borne
viruses if injection equipment is shared, using a drop of fluorescent
dye to simulate a drop of blood. When viewed under a black light,
the cooker, cotton, water and even the fingers of the woman who
prepared the injection equipment glowed in the dark, demon-
strating how easily contamination of these items can occur.
Women were also taught how to disinfect their syringes with
bleach.
The counselor then used a ‘risk ladder’ to illustrate injection
behaviors ordered from least risky (i.e. not using drugs) to most
risky (i.e., using somebody’s syringe, etc.), and an action item for
each that was written on a flash card. The participant was asked to
place the card along the ladder, justifying its location. The
counselor then used MI techniques to elicit information on the
woman’s own risky injection behaviors, her perceived advantages
and disadvantages of doing so, and the ‘‘decisional balance’’
approach to facilitate her personal realization that the negative
outcomes associated with these behaviors outweighed the positive
outcomes. The counselor then prompted the participant to
verbally propose possible alternatives to sharing injection equip-
ment, which helped build her personal motivation for change. A
short role play was then used to help her identify barriers to safer
injection, through which women practiced negotiating safer
injection skills. Finally, participants were encouraged to set at
least one goal to reduce their injection risks.
Group C, the Interactive Sexual Risk Intervention Condition
and Didactic Injection Risk Intervention Condition, required 60
minutes to complete. Participants randomized to this condition
and received the interactive sexual risk reduction intervention, and
the didactic injection risk intervention described previously. The
Interactive Sexual Risk portion of the Intervention required
approximately 30 minutes to complete. The interactive sexual risk
intervention was based on components of the Mujer Segura [26] and
Fastlane [35] interventions, both of which combined the principles
of SCT and TRA and used MI to facilitate condom negotiation
skills. Components of these interventions were adapted to
incorporate strategies for negotiating condom use within the
context of their own, or their partner’s substance use, and were
extensively piloted among FSW-IDUs in Tijuana and Cd. Juarez
as previously described [29].
Briefly, the counselor and the participant discussed her
awareness of unsafe sex and associated risks (e.g., HIV, STIs,
pregnancy). The counselor probed the participant on her
experiences with condom use/non-use, substance use during sex,
and her perceived need and desire to change high risk sexual
behaviors. She then showed the participant how to put a condom
on properly using a model. The counselor then used MI
techniques to prompt the participant to discuss the advantages
and disadvantages she perceived to having unprotected sex and
barriers to using condoms with regular or casual partners. The
counselor then used the ‘‘decisional balance’’ approach to help the
participant articulate that, in most cases, the positive consequences
associated with condom use strongly outweighed the negative
consequences. The counselor then helped the participant actively
problem-solve her personal barriers to condom use, define
achievable goals and arrive at a plan of action. The participant
and counselor then engaged in a role-play to practice her condom
negotiation skills.
Group D, the Interactive Injection Risk Intervention and
Interactive Sexual Risk Intervention, also required 60 minutes to
Combination HIV/STI Intervention among FSW-IDUs
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complete. Participants randomized to this condition received the
interactive modules of the injection risk intervention and the
sexual risk intervention, described above.
Outcome ascertainment. At baseline and quarterly for 12
months, all subjects were tested for HIV and four other STIs
(Treponema pallidum, Neisseria gonorrhoeae, Chlamydia trachomatis, and
Trichomonas vaginalis). The primary intervention outcome was
combined incidence of HIV/STIs, therefore those infected at
baseline were excluded. HIV serostatus was ascertained using the
‘‘Determine’’H rapid antibody test (Abbott Pharmaceuticals,
Boston, MA); reactive samples were confirmed using an HIV-1
enzyme immunoassay and immunofluorescence assay. Syphilis
serology was ascertained by the rapid plasma reagin (RPR) test
(DetermineTM Syphilis TP; Abbott Pharmaceuticals, Boston, MA);
RPR-positive tests were subjected to the Treponema pallidum particle
agglutination assay (TPPA) (Fujirebio, Wilmington, DE, USA).
Syphilis titers $1:8 were considered to be active infections.
Initially, testing for Gonorrhoea and Chlamydia (GC/CT) was
conducted using a vaginal swab rapid test kit (BioStarH OIAH GC
and CHLAMYDIA) and positive samples were confirmed on
urine specimens using Transcription-Mediated Amplification
(TMA) (Genprobe, San Diego, CA). Following a change in
CDC recommendations [36], the GC/CT protocol was modified
in March 2009 to accommodate GC/CT urine screening and
TMA on all specimens. Trichomonas vaginalis was detected from
vaginal swabs using the OSOMH Trichomonas Rapid Test
(Genzyme diagnostics, San Diego, CA). The San Diego County
Health Department (SDCPHL) conducted all confirmatory tests.
Pre- and post-test counseling and referrals. Pre-test
HIV/STI counseling was performed as per CDC and Mexican
guidelines. Participants with an indeterminate or reactive HIV
rapid test were referred to Municipal specialty clinic (CAPASITS)
for further expedited follow-up while confirmatory test results were
pending. Women testing positive for STIs were provided
immediate free treatment by the study nurse. At quarterly
follow-up visits, participants were re-tested for HIV and STIs
and underwent follow-up interviews with recall periods that
referred to the period since the last interview. Participants received
modest monetary reimbursements ranging from $5 to $25 USD for
baseline and follow-up visits, and ‘check-ins’.
Statistical Analysis
To ensure that randomization assured balance between the
intervention groups, we compared the four intervention groups
with respect to binary outcomes by using Chi-Squared tests and
with respect to continuous outcomes by using Kruskal-Wallis tests.
Combined HIV/STI incidence density was calculated by taking
the ratio between the number of incident cases and the number of
person-years at risk accumulated over the 12-month study period
for participants who had at least one follow-up visit and tested
negative at baseline for HIV and any of the aforementioned STIs.
Incident cases were assumed to have occurred at the mid-point of
the follow-up interval during which the new infection was detected
(i.e., ‘‘time at risk’’ for incident cases was represented by the time
from baseline to the occurrence of the ‘‘first’’ STI). For the
participants who did not contract any incident STIs during the
study, the ‘‘time at risk’’ was represented by the time from baseline
to the last time they had lab results available. The number of
person years at risk was calculated by summing the ‘‘time at risk’’
for each participant. Finally, the incidence density per 100 person
years was calculated by taking the ratio between the number of
incident cases and number of person years at risk and multiplying
it by 100.
Following recommendations for analysis of factorial trials [37],
we first assessed whether the interactive formats of each
intervention acted independently of each other. For example, for
the HIV/STI incidence outcome, we tested whether there was a
significant difference –either in direction or magnitude–, with
respect to the outcome between the group that received the
interactive sex risk intervention (Group C) and the group that
received both the interactive sex risk and the interactive injection
risk intervention (Group D). For the secondary outcomes, we
tested whether an interaction existed between the group that
received the interactive injection risk intervention and time, versus
the group that received both the interactive sex and interactive
injection intervention. For outcomes where there was no evidence
of dependency between the two groups in question, the
intervention effect was evaluated ‘‘at the margins,’’ whereas for
outcomes where such a dependency was present, the intervention
effect was evaluated ‘‘inside the table.’’ More specifically, the
intervention effect on the primary outcome (i.e., incidence density)
was evaluated ‘‘at the margins’’, whereas the corresponding effect
on the secondary outcomes evaluated ‘‘inside the table’’.
To evaluate the impact of the interactive sexual risk intervention
on HIV/STI incidence, we conducted Poisson regression with
robust variance estimation via Generalized Estimating Equations
(GEE) [38], using the logarithm of the time (years) spent at risk as
an offset variable to account for the varying length of time at risk
per subject. A natural logarithm link function was used to relate
the probabilities of the outcome to the linear combination of the
predictors. We first examined the main effects of intervention
group (A, B, C, D), study location (Tijuana vs. Ciudad Juarez) and
the interaction between the two, respectively. Because the
interaction between the intervention group and site was signifi-
cant, we subsequently performed stratified analyses where the
main effect investigated was the effect of the intervention group.
GEE with robust variance estimation was chosen as the analytical
method for evaluating the primary outcome to correct for over-
dispersion. Specifically, one of the main assumptions for the
traditional Poisson regression is that the conditional mean equals
the conditional variance. At the modeling stage, this assumption
was assessed by the deviance statistic divided by the degrees of
freedom, which indicated the presence of moderate over-
dispersion. In such cases, [38] recommend using robust standard
errors for the parameter estimates. The quasi-likelihood under the
independence model criterion (QIC) described by Pan [39] was
used to compare GEE models to select the most parsimonious
model.
To examine our secondary outcomes (frequency of receptive
needle sharing, and sharing of injection paraphernalia (cookers,
cottons, water and dividing drugs with a used syringe)), we
conducted ordinal logistic regression for correlated data via GEE
with the correlation matrix estimated empirically from the data.
The final analyses for the secondary outcomes were also stratified
by site, due to significant differences between sites [29] and
significant interactions involving site. Prior to stratification, the
main effects investigated were intervention group (Group AC vs.
Group BD), visit (Baseline, Visit 2, Visit 3, and Visit 4), study
location (Tijuana vs. Ciudad Juarez) and all two-way and three-
way interactions between them. After stratification, our primary
interest was the interaction between visit and intervention group,
with a significant p-value being indicative of an intervention effect.
A cumulative logit link function was used to relate the cumulative
probabilities of the outcome to the linear combination of the
predictors. We chose the ordinal logistic model because our
outcomes were ordinal (1 = never, 2 = sometimes, 3 = half the
time, 4= often, 5= always). The assumption required by the
Combination HIV/STI Intervention among FSW-IDUs
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ordinal logistic models is the proportional odds assumption. This
assumption was evaluated for all the ordinal logistic regression
models by score tests which yielded p-values well above 0.05,
suggesting that the ordinal logistic models were reasonable for our
data. Additionally, an injection risk index (IRI) score was
determined based on an index developed for the Drug User’s
Intervention Trial [32], by calculating the average score between
responses to injection risk indicators, with higher scores repre-
senting higher risk. Gamma regression for correlated data via GEE
with an unstructured correlation structure was used to evaluate the
impact of the intervention on the mean IRI. A natural logarithm
link function was used to relate the mean of the dependent variable
to the linear combination of the predictors. The Gamma
regression model was chosen primarily because the IRI is a
continuous variable with strictly positive values ranging between
one and five, with the distribution of values skewed to the right and
with the variance of the observations not constant but rather
increasing with the mean (as indicated by plotting the residuals
from linear normal models against predicted values). Furthermore,
the plot of the residuals against of the predicted values from the
Gamma models suggested a linear relationship indicating that the
gamma models were a reasonable fit for our analyses.
In regression models, we controlled for baseline risk behaviors
as covariates. Specifically, at the modeling stage, we considered all
potential covariates and their interaction with the main effects and
each other. Since interactions usually require more power to
detect, a conservative alpha level of 0.10 was used. Graphical
displays were used to examine whether the interactions in question
were significant and/or confounding. No interactions involving
covariates are present in the final models and the covariates
included in the final models are all statistically significant at a 0.05
alpha level. Multi-collinearity was assessed for each model and
ruled out by the appropriate values of the Variance Inflation
Factors and the Condition Indexes. All outcome analyses were
based on the assumption that the missing data was missing
completely at random (MCAR). This assumption was tested and
confirmed by the appropriate values yielded by the Chi-Square
test for MCAR [40].
Results
Of 1132 women who were screened for eligibility, 548 (48.4%)
were excluded because they were ineligible (n = 497), or were
deemed eligible but did not return for baseline assessment (n = 61).
Reasons for exclusion were previously described [29]. Therefore,
584 women enrolled and provided informed consent (284 in
Tijuana and 300 in Cd. Juarez), all of whom underwent
interviewer-administered surveys and provided biological samples
at baseline, and were randomized to Group A (n = 144), Group B
(n = 146), Group C (n= 148) and Group D (n= 146).
Over twelve months, only 17 participants (2.9%) did not return
for at least one follow-up visit, primarily due to deaths which were
unrelated to study participation (n= 10). The remaining 7
participants could not be located. Of the 567 participants who
had at least one follow-up visit, an average of 12% per follow-up
visit (11% in Tijuana and 13% in Ciudad Juarez) had missing
data. However, testing revealed that the missing data was missing
completely at random, which allowed for the inclusion of all 567
participants in the outcome analyses.
Compared to participants in Cd. Juarez, Tijuana participants
reported higher levels of formal education (8 vs. 6 years, p,.001).
In the past month, a higher proportion of Tijuana participants
injected drugs at least daily (96.8% vs. 91.3%, p= .005) and often/
always injected drugs with a client (47.3% vs. 17.3%, p,.001),
compared to participants in Cd. Juarez, but Cd. Juarez
participants were more likely to report dividing drugs with a used
syringe (74% vs. 63.3%, p= 0.006). Tijuana participants scored
higher on the IRI (p = 0.01).
Compared to Tijuana participants, those in Cd. Juarez were
younger when they began sex work (median: 19 vs. 20 years,
p = 0.02), had more male clients (median: 68 vs. 15 per month,
p,0.001), and had more unprotected vaginal/anal sex acts in the
past month (median: 33 vs. 25 per month, p,0.001). Although
participants from Cd. Juarez earned more money from sex work
(median: 1140 vs. 770 USD per month, p,0.001), they earned less
per unprotected vaginal sex act (median: 15 vs. 25 USD per act,
p,.001). On the other hand, Tijuana participants reported having
greater access to condoms (42.2% vs. 17.3%, p,.001) and sterile
syringes (43.0% vs. 16.1%, p,.001) in the past year compared to
participants in Cd. Juarez. At baseline, Cd. Juarez participants had
higher prevalence of lifetime syphilis (i.e., RPR positive and TPPA
confirmed syphilis infection; 32.7% vs. 16.2%, p,.001) than
participants in Tijuana, but a higher proportion of syphilis cases in
Tijuana had titers $1:8 relative to Cd. Juarez (50% vs. 26.8%,
p= 0.006).
Comparing baseline characteristics by intervention condition
and site suggested that randomization achieved relatively balanced
groups (Table 1) with a few exceptions. In Tijuana, participants
receiving the interactive formats of both interventions (Group D)
were less likely to report dividing drugs with a used syringe at
baseline compared to the other groups (p,0.05), and participants
receiving the interactive injection risk intervention and didactic sex
risk intervention (Group B) were older when they began sex work
than participants in Group A (median: 22 years versus 19 years,
p,0.05). In Cd. Juarez, participants in Group A were older than
those in Group B (p,0.05).
By definition, all participants reported either receptive needle
sharing or injection with used injection equipment within the last
month (e.g., receptive needle sharing: 96.2%; sharing a cooker:
96.4%; sharing a cotton filter: 88.0%; sharing rinse water: 94.5%).
At baseline, 24.6% of the sample tested positive for syphilis (of
whom 34.3% had titers $1:8); 33.6% had trichomoniasis, 12%
had Chlamydia and 2.2% had gonorrhea.
In the primary intent-to-treat analysis stratified by site, there
was no indication of dependence between the group that received
the interactive sexual risk intervention (Group C) and the group
that received both the interactive sexual risk and the interactive
injection risk intervention (Group D) for Tijuana, suggesting that
the intervention effect on HIV/STI incidence could be analyzed
‘‘at the margins’’. However, we did observe a significant
dependence between the two groups for Cd. Juarez, indicating
that this analysis should be conducted ‘‘inside the table’’ [37]. In
Tijuana, HIV/STI incidence was lower among women random-
ized to Groups C and D (35.52 and 30.01 per 100 py, respectively)
compared to that among women in Group A (64.26 per 100 py)
(Table 2). In Cd. Juarez, women randomized to Group C also had
lower HIV/STI incidence than women in Group A (34.65 vs.
66.10 per 100 py), but HIV/STI incidence for Group D was not
significantly different. The final Poisson regression model for
Tijuana (Table 3) found that HIV/STI incidence for women
assigned to Group C and D was 62% and 63% lower than women
assigned to Group A (i.e., Adjusted relative incidence (ARI: 0.38
and 0.37 (95% CIs: 0.16, 0.89). This model controlled for the
number of unprotected sex acts with non-regular clients in the
month prior to enrollment, and being arrested in the 6 months
prior to enrolment. The final Poisson regression model for Cd.
Juarez (Table 4) found that HIV/STI incidence was 56% lower
for women randomized to Group C compared to Group A (ARI:
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0.44; 95% CI: 0.19, 0.99). This model controlled for the amount
earned per unprotected sex act at baseline, and cocaine use in the
month prior to baseline.
The analysis of secondary outcomes revealed no significant
dependence between the group that received the interactive
injection risk intervention (Group B) and the group that received
both the active injection and the active sex intervention (Group D)
at any of the time points, indicating that these analyses could be
conducted ‘‘at the margins’’ for both sites. For Cd. Juarez, the
interactive injection risk intervention was associated with signifi-
cant declines in receptive needle sharing (Figure 1; p= 0.04), and
IRI score (p = 0.01; results not shown) and sharing of individual
injection paraphernalia items (i.e., cookers, filters, rinse water;
results not shown). In an ordinal regression model, the interaction
between visit 4 and intervention group was significant (p,0.0001),
indicating that a significantly higher reduction in the proportional
odds of receptive needle sharing was achieved in the intervention
group as compared to the control group after 12 months of follow-
up (results not shown).
Although the slope of the decline in receptive needle sharing
and IRI score was steeper for Tijuana compared to Cd. Juarez,
there were no significant differences in the proportional odds of
receptive needle sharing (Figure 1) or the predicted mean IRI
scores comparing groups in Tijuana that received the interactive
injection risk intervention to those that did not (results not shown).
Discussion
This combination prevention trial conducted in two Mexican-
U.S. border cities is the first to achieve simultaneous, significant
reductions in both sexual and injection risk behaviors among sex
workers who inject drugs. Analyses of the interactive safer sex
intervention extend the findings of the earlier Mujer Segura trial
[26], and confirm that FSW-IDUs can experience significant
reductions in HIV/STI incidence in the context of their drug use
and/or that of their commercial sexual partners, as other
researchers have advocated [41]. Indeed, the magnitude of the
risk reduction in this trial (50–60%) surpassed that of the Mujer
Segura trial, and the strong intervention effect we observed was
sustained over one year in both cities. The impact of the
intervention on HIV/STI incidence was slightly greater in
Tijuana than Cd. Juarez, perhaps because women in the former
city reported having greater access to condoms.
Our findings also demonstrate that condom provision and HIV
prevention education delivered in a lecture format is not sufficient
for achieving reductions in HIV/STI incidence among FSW-
IDUs. In the case of male condoms, negotiation skills are typically
required to ensure that sex workers can convince their partners to
use them. Our findings are consistent with other interventions that
have shown that FSWs can be taught to successfully negotiate
condom use with clients in other settings[42–45], but extends this
research since our intervention was associated with significant
reductions in HIV/STI incidence and can be delivered within 30
minutes by peer workers with minimal training. An intervention is
underway to determine whether a similar intervention approach is
efficacious among male clients of FSWs in Tijuana.
Although the two groups of women who received the interactive
sexual risk intervention in Tijuana experienced nearly identical
reductions in HIV/STI incidence, only the group receiving the
interactive sexual risk intervention in combination with the
didactic format of the injection risk intervention achieved a
significant decrease in HIV/STI incidence. Women in Cd. Juarez
receiving the interactive formats of both interventions may not
have experienced similar declines in HIV/STI incidence because
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they tended to engage in higher risk sexual behaviors than their
counterparts in Tijuana. A more intensive intervention may be
needed for the highest risk subgroup, among which simultaneous
risk reductions in both injection and sexual risks may be more
challenging with brief interventions.
Interestingly, the interactive injection risk intervention was
associated with significant reductions in receptive needle sharing
and sharing of paraphernalia in Cd. Juarez, but not in Tijuana. In
Tijuana, women randomized to both the interactive and didactic
formats of the intervention dramatically reduced their injection
risk behaviors relative to baseline–and to a greater extent than
women in Cd. Juarez– but there was no difference between groups
of Tijuana women who received the two intervention formats.
This was an unexpected finding, but we were aware that the
number of syringes and kits containing injection paraphernalia
(‘prevenkits’) increased markedly in Tijuana versus Cd. Juarez
during the study period (Figure 2). In a post-hoc analysis, we tested
the hypothesis that increased access to syringes may have
dampened the intervention effect. Specifically, we offered the
variable ‘reported easy access to sterile syringes’ into the ordinal
regression model for Cd. Juarez and found that the syringe access
variable became significant (POR: 0.69; 95% CI: 0.50–0.94) and
the variable representing the interactive injection risk intervention
lost statistical significance (POR=1.06; 95% CI: 0.79–1.42), in
support of our hypothesis. These findings suggest that the didactic
format of the injection risk intervention coupled with expanded
access to sterile injection equipment is both necessary and sufficient
for achieving significant reductions in injection risk, supporting
literature that underscores the critical role of sterile syringe
coverage through syringe exchange programs (NSPs), pharmacies
and over-the-counter syringe sales [46,47].
NSPs now exist in six Mexican states including Baja California
and Chihuahua; however, syringe coverage is uneven and very
low. Although it is legal to purchase syringes in Mexico without a
prescription, IDUs report persistent barriers to purchasing and
carrying syringes in both Tijuana and Cd. Juarez [48,49]. Being
arrested for carrying used or unused syringes by police has been
associated with both receptive needle sharing [49], and HIV
infection [5] in both cities. This suggests that structural
interventions such as police education programs will be needed
Table 2. HIV/STI incidence density over 12 months: Overall, by intervention group and site.
Group Intervention group
#of incident
cases*
# of people
at risk
#of py at
risk
Incidence density
per 100 py (95% CI)
Entire Sample
A Didactic injection and sex interventions (control) 31 69 47.68 65.02 (42.13,87.91)
B Interactive injection/Didactic sex interventions 31 63 45.82 67.66 (43.84, 91.47)
C Interactive sex/Didactic injection interventions 18 63 51.32 35.08 (18.87,51.28)
D Interactive injection and sex interventions 26 63 48.11 54.04 (33.27, 74.81)
Tijuana
A Didactic injection and sex interventions (control) 18 41 28.01 64.26 (34.58, 93.95)
B Interactive injection/Didactic sex interventions 11 31 23.88 46.067(18.84, 73.29)
C Interactive sex/Didactic injection interventions 9 33 25.34 35.52 (12.31, 58.72)
D Interactive injection and sex interventions 8 32 26.66 30.01 (9.21, 50.81)
Cd. Juarez
A Didactic injection and sex interventions (control) 13 28 19.67 66.10 (30.17,102.02)
B Interactive injection/Didactic sex interventions 20 32 21.94 91.15 (51.20, 131.09)
C Interactive sex/Didactic injection interventions 9 30 25.98 34.65 (12.01, 57.29)
D Interactive injection and sex interventions 18 31 21.45 83.90 (45.14,122.66)
*By STI: 1 HIV, 24 lifetime syphilis, 6 syphilis titers .= 1:8, 23 Chlamydia, 3 gonorrhea, and 66 trichomoniasis. Fifteen participants presented with more than one STI at
the same visit, so incident cases by STI do not add to the same number as the total number of incident HIV/STIs.
doi:10.1371/journal.pone.0065812.t002
Table 3. Intervention effects on HIV/STI incidence after 12 months: Tijuana*.
Predictor
Adjusted
Relative Risk 95% CI p-value
Group A: Didactic Sex Risk Intervention+Didactic Injection Risk Intervention
Group B: Interactive Injection Risk and Didactic Sex Risk Intervention 0.88 0.40, 1.94 0.74
Group C: Interactive Sex Risk Intervention and Didactic Injection Risk Intervention 0.38 0.16, 0.89 0.03
Group D: Interactive Sex Risk Intervention+Active Injection Risk Intervention 0.37 0.16, 0.89 0.03
# of unprotected sex acts with non-regular clients for month prior to enrollment 1.01 1.01, 1.02 ,0.001
Arrested during the six months prior to enrollment 2.68 1.39, 5.15 0.003
*excluding women who tested HIV-positive or had STIs at baseline.
doi:10.1371/journal.pone.0065812.t003
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to ensure that behavior changes achieved by this and other
interventions are not erased.
Our findings from Cd. Juarez suggest that the interactive format
of the injection risk intervention has value in settings with sub-
optimal syringe access, such as those with limited resources or laws
and policies that restrict IDUs’ access to syringes. Despite a
plethora of studies demonstrating the efficacy of NSPs for reducing
HIV transmission, they exist in only 82 countries where HIV
infection has been reported among IDUs, and coverage is
extremely low at an estimated 22 syringes distributed per IDU
per year [50] which is insufficient to prevent HIV transmission. In
most countries, no access to syringes is provided in jails/prisons,
despite ample access to drugs, suggesting that our injection risk
intervention may benefit IDUs in detention facilities.
Our study was limited by the fact that it was not originally
designed to test the efficacy of these interventions by site. We were
also under-powered to examine the impact of the sexual risk
intervention on incidence of HIV or individual STIs alone; indeed,
there was only one incident HIV case during follow-up. Further,
our study focused on condom negotiation within the context of
sexual transactions, rather than intimate relationships with non-
paying partners. Despite these shortcomings, we observed
significant intervention effects on combined HIV/STI incidence
that did not wane after 12 months. Our analysis of injection risk
outcomes was based on self-reported behaviors, rather than a
biologic outcome because HCV prevalence exceeded 90% among
IDUs in both cities [51]. While reports of injection behaviors could
have been subject to socially desirable responding, we had no
reason to expect that this would occur differentially across
Table 4. Intervention effect on 12 months HIV/any STI incidence rate: Ciudad Juarez*.
Predictor
Adjusted
Relative Risk 95% CI p-value
Intervention Group (ref =Didactic)
Interactive Injection Risk Intervention 1.15 0.58, 2.28 0.68
Interactive Sex Risk Intervention 0.44 0.19, 0.99 0.05
Interactive Sex Risk Intervention & Interactive Injection Risk 1.12 0.56, 2.25 0.76
Amount earned per unprotected sex act at baseline (per USD increase) 1.02 1.00, 1.05 0.04
Used cocaine the month prior to baseline 1.66 0.98, 2.80 0.05
*excluding women who tested HIV-positive or had STIs at baseline.
doi:10.1371/journal.pone.0065812.t004
Figure 1. Changes in Proportional Log Odds of Receptive Needle Sharing among Participants in Tijuana and Ciudad Juarez
Receiving Interactive or Didactic Injection Risk Interventions.
doi:10.1371/journal.pone.0065812.g001
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intervention conditions, because all four groups received the same
interventions and only the format of the interventions differed.
Further, since interviewers were blind to intervention group, there
is no reason to expect that information elicited from participants
would differ across intervention groups.
In summary, we found that a brief, interactive counseling
session was successful in reducing HIV/STI incidence by over
50% over a twelve month follow-up period among FSW-IDUs in
two Mexican-U.S. border cities. With respect to reducing injection
risk behaviors, our results indicate that it is more important to
scale-up free access to injection equipment at the community-level
with minimal harm reduction education than to provide an
intensive individual-level intervention without adequate syringe
coverage. However, our interactive injection risk intervention may
be useful for many settings where sterile syringe coverage cannot
be sufficiently increased. Given that both interventions are brief
and can be offered with minimal training, future studies are
needed to examine their contribution to combination prevention
approaches in settings where FSWs and IDUs receive other
services such as drug abuse treatment programs, NSPs, reproduc-
tive health clinics and detention facilities, as well as structural
interventions such as those involving managers, madams and
clients.
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